Türkiye’nin batısında, Kütahya ilinde sphaeridium fabricus, 1775 (coleoptera: hydrophilidae) cinsi üzerine bir çalışma

Coprophilous Hydrophilidae were sampled from June 2010 to May 2011 using baited pitfall traps in 14 localities at different altitudes (469m-1810m) in Kütahya, western Turkey. As a result of the study, a total of 668 samples belonging to 5 species were identified. The identified specimens are Sphaeridium bipustulatum Fabricius, 1781, S. lunatum Fabricius, 1792, S. marginatum Fabricius, 1787, S. scarabaeoides (Linnaeus, 1758) and S. substriatum Faldermann, 1838, among which S. lunatum is recorded from Turkey for the first time. S. bipustulatum and S. marginatum, which made up 80.69% of all collected beetles determined as eudominante. The highest number of specimens was obtained from December to April meaning that the Sphaeridium community in the study area reached its highest number in winter and spring.Türkiye batısında Kütahya’da, Haziran 2010’dan Mayıs 2011’e kadar, 14 lokalitede ve farklı yüksekliklerde (469m1810m) yemli çukur tuzaklar kullanılarak koprofil Hydrophilidae örnekleri toplanmıştır. Çalışma sonucunda toplam 5 türe ait 668 örnek tespit edilmiştir. Toplanan örneklerin Sphaeridium bipustulatum Fabricius, 1781, S. lunatum Fabricius, 1792, S. marginatum Fabricius, 1787, S. scarabaeoides (Linnaeus, 1758) ve S. substriatum Faldermann, 1838 türlerine ait oldukları belirlenmiştir. S. lunatum Türkiye’den ilk kez kayıt edilmiştir. Toplanan böceklerin %80,69'unu oluşturan S. bipustulatum ve S. marginatum en baskın türler olarak belirlenmiştir. Aralık ayından Nisan ayına kadar yoğun örnek elde edilmiş olması, çalışma alanı içerisindeki Sphaeridium popülasyonlarının kış ve ilkbahar döneminde en yüksek birey sayılarına ulaştığını göstermektedir

Permanent cardiac pacing in a 2.5 month-old infant with severe cyanotic breath-holding spells and prolonged asystole

We report the case of a 2.5 month-old infant with cyanotic breath-holding spells, loss of consciousness and seizures. Prolonged asystole up to 70 s despite cardiopulmonary resuscitation was documented by 24 hour Holter monitoring. An epicardial pacemaker was implanted followed by no further loss of consciousness and seizures during spells in a six month follow-up period. (Cardiol J 2011; 18, 6: 704–706

Left ventricular non-compaction in children and adolescents: Clinical features, treatment and follow-up

Background: Left ventricular non-compaction (LVNC) is a specific cardiomyopathy that occurs following a disruption of endomyocardial morphogenesis. This study presents clinical findings, diagnostic features, treatment and follow-up of pediatric patients diagnosed with LVNC. Methods: Patients with LVNC who were followed from January 2006 to March 2010 were included in this study. Diagnosis was made with the use of characteristic findings of magnetic resonance imaging and echocardiography. Holter electrocardiography and metabolic screening tests were also performed in all patients. Results: A total of 24 patients were studied (18 male, six female). Patient age at diagnosis was 50 ± 60 months (eight days to 15 years). Average follow-up period was 22 ± 12 months (four months to four years). Findings at diagnosis were as follows: eight (33%) patients had heart failure, five (20%) had rhythm abnormalities, five (20%) had cardiomegaly, two had murmurs, two had cyanosis, and two presented with fatigue. Ten (41%) patients had been followed previously with other diagnoses. In 21 (87.5%) patients, electrocardiographic abnormalities were noted, especially left ventricular hypertrophy and ST-T changes. Patients had an average ejection fraction of 46% (18-73%) and three of them had additional congenital heart disease (patent ductus arteriosus, aortopulmonary window and complex cyanotic heart disease). Scanning for metabolic diseases revealed fatty acid oxidation disorder in one patient, and mitochondrial disease in another. During follow-up, a permanent pacemaker was implanted in a patient with severe bradycardia and ventricular dysfunction, and three patients died. Conclusion: LVNC can be diagnosed at any age from newborn to adolescent and has a variable clinical course. Closer study of patients with cardiomegaly and heart failure can reduce delays in diagnosis of LVNC. (Cardiol J 2011; 18, 2: 176-184

Evaluation of coronary artery abnormalities in Williams syndrome patients using myocardial perfusion scintigraphy and CT angiography

Background: Sudden death risk in Williams syndrome (WS) patients has been shown to be 25–100 times higher than in the general population. This study aims to detect coronary artery anomalies and myocardial perfusion defects in WS patients using noninvasive diagnostic methods. Methods: This study features 38 patients diagnosed with WS. In addition to physical examination, electrocardiography, and echocardiography, computed tomography (CT) angiography and rest/dipyridamole stress technetium-99m sestamibi (99mTc-sestamibi) single photon emission computed tomography (SPECT) myocardial perfusion scintigraphy (MPS) were performed. Results: Twenty-one (55%) patients were male; 17 (45%) were female. The average patient age was 12 ± 5 years (2.5–26 years); the average follow-up period was 7.2 ± 4.2 years (6 months–18 years). Cardiovascular abnormalities were found in 89% of patients, the most common one being supravalvar aortic stenosis (SVAS). CT angiography revealed coronary anomalies in 10 (26%) patients, the most common ones being ectasia of the left main coronary artery and proximal right coronary artery as well as myocardial bridging. SVAS was present in 80% of patients with coronary artery anomalies. 99mTc-sestamibi SPECT MPS revealed findings possibly consistent with myocardial ischemia in 29% of patients, and ischemia in 7 out of 10 patients (70%) with coronary anomalies shown on CT angiography (p = 0.03). Conclusions: Coronary artery abnormalities are relatively common in WS patients and are often accompanied by SVAS. CT angiography and dipyridamole 99mTc-sestamibi SPECT MPS seem to be less invasive methods of detecting coronary artery anomalies and myocardial perfusion defects in WS patients

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center

Introduction : Familial hypercholesterolemia (FH) is characterized by severe hypercholesterolemia that can result in coronary artery disease occurring at an early age. If patients are not cured with lipid-lowering drugs and diets, lipid apheresis may be an effective treatment option in these cases. Here, we evaluate the efficacy, selectivity and safety of the DALI apheresis technique

vittata vittata (Fabricius, 1775), Gymnopleurus sturmii MacLeay, 1821, Cheironitis ungaricus (Herbst, 1789), Caccobius histeroides (Ménétriés, 1832), Onthophagus (Palaeonthophagus) coenobita

Bu çalışmada Glaphyridae and Scarabaeidae örnekleri toplanmıştır. Bu çalışmanın sonucunda toplam 34 tür tespit edilmiştir. Eulasia (Rudeulasia) papaveris (Sturm, 1843), Eulasia (Vittateulasia) vittata vittata (Fabricius, 1775), Gymnopleurus sturmii MacLeay, 1821, Cheironitis ungaricus (Herbst, 1789), Caccobius histeroides (Ménétriés, 1832), Onthophagus (Palaeonthophagus) coenobita (Herbst, 1783), Onthophagus (Palaeonthophagus) muelleri P. Novak, 1921, Onthophagus (Palaeonthophagus) osellai Pittino, 1982, Onthophagus (Palaeonthophagus) ovatus (Linnaeus, 1767) Eskişehir faunası için ilk kez kaydedilmiştir. Tüm türlerin Palearktik Bölge ve Türkiye'deki yeni dağılımları verilmişti

Pulmonary arteriovenous malformation associated with Osler-Weber-Rendu syndrome

Osler-Weber-Rendu syndrome is a relatively common vascular displasia of children presented with telengiectasias of skin, mucosa, and visceral organs and arteriovenous malformations. We reported a 9-year-old boy diagnosed as having Osler-Weber Rendu syndrome with his central cyanosis, clubbing, facial and nasal mucosal telengiectasias and right pulmonary arteriovenous malformation during an attack of acute rheumatic carditis. After relief of the acute rheumatic carditis attack, his arteriovenous malformation was treated with coil embolisation by cardiac catheterization. (Turk Arch Ped 2011; 46:264-6

Balloon valvuloplasty for aortic stenosis using umbilical vein access in a newborn: First experience in Turkey

Despite risk of development of postprocedural aortic insufficiency, and restenosis at midterm, balloon valvuloplasty is an effective therapy for severe congenital aortic valve stenosis No consensus currently exists regarding optimal vascular approach for balloon dilatation in newborns with critical or severe aortic valve stenosis. Critical aortic valve stenosis in newborns must be treated promptly and effectively. Surgical therapy has been associated with significant rates of morbidity and mortality. Transcatheter therapy has significant advantages in this group of patients when compared with, surgical treatment. Percutaneous balloon dilatation is frequently performed as emergent therapy of valve ste-nosis, with various options for vascular approach. While umbilical artery and vein access has been tried in very few number of patients in the treat-ment of critical aortic valve stenosis and aortic coarctation. Umbilical artery, and vein access should be thought as an alternative to balloon dilatation of critical aortic stenosis. With available catheters this is a safe, simple, and effective procedure even in newborns weighing under 2.5 kg